Quick Answer
BioNexus Gene Lab Corp reported Total Assets of $10.43 million for fiscal year 2024.
BioNexus Gene Lab Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $10.43M | -8.5% |
| 2023 | $11.40M | +30.4% |
| 2022 | $8.74M | -8.7% |
| 2021 | $9.57M | -5.3% |
| 2020 | $10.12M | +721.6% |
| 2019 | $1.23M | -25.5% |
| 2018 | $1.65M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.62M | -30.7% | -19.1% |
| June 30, 2025 | $9.42M | -15.4% | -0.6% |
| March 31, 2025 | $9.48M | -15.1% | -9.1% |
| December 31, 2024 | $10.43M | -8.5% | -5.1% |
| September 30, 2024 | $11.00M | — | -1.3% |
| June 30, 2024 | $11.14M | +41.0% | -0.2% |
| March 31, 2024 | $11.16M | +36.3% | -2.1% |
| December 31, 2023 | $11.40M | +30.4% | +44.3% |
- BioNexus Gene Lab Corp showed a decrease of -8.5% in Total Assets compared to the prior fiscal year.
- Over the 2018–2024 period, BioNexus Gene Lab Corp’s total assets has grown by 531.5% (from $1.65 million to $10.43 million).
- The most recent figure is from BioNexus Gene Lab Corp’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: